VALOR II and VALOR Results Published for Medtronic's TEVAR Devices
October 23, 2012—In the Journal of Vascular Surgery, Ronald M. Fairman, MD, et al report 30-day and 12-month results from the VALOR II study of endovascular treatment with the Valiant thoracic stent graft system (Medtronic, Inc., Minneapolis, MN) in patients with descending thoracic aortic aneurysms of degenerative etiology (2012;56:1222–1231). The Valiant stent graft is an evolution of Medtronic's Talent thoracic stent graft, noted the investigators.
